First Stakeholder Webcast of 2026 on BOT+BAL Access and Updates – Agenus
Agenus/LinkedIn

First Stakeholder Webcast of 2026 on BOT+BAL Access and Updates – Agenus

Agenus shared a post on LinkedIn:

“Agenus will host its first Stakeholder Webcast of 2026 on Wednesday, January 28 at 4:00 p.m. ET.

This live session will bring together Agenus leadership and an international oncology leader to discuss:

  • The momentum driving global access to BOT+BAL for eligible patients
  • Clinical development and strategic partnerships updates
  • Ensuring operational readiness for increased interest

Featured Speakers:

Dr. Robin Jones: The Royal Marsden/Institute of Cancer Research (London, UK)
Dr. José Iglesias: Chief Medical Affairs Officer, Agenus
Dr. Garo Armen: Founder, Chairman, and CEO, Agenus

The event will be moderated by Garo Armen, PhD, and will conclude with a live Q&A.

Submit questions in advance to: ask@agenusbio.com

Register at:

Read full release.”

More posts about Agenus.